Pancreatic enzyme supplementation versus placebo for improvement of gastrointestinal symptoms in non-responsive celiac disease: A cross-over randomized controlled trial.
Frontiers in Medicine(2022)
摘要
In this prospective, cross-over randomized, placebo-controlled study, PES did not improve symptoms in patients with NRCD. It is unclear whether this is a trial effect or related to administration of omeprazole.
更多查看译文
关键词
diarrhea,dyspepsia,exocrine pancreatic insufficiency,malabsorption,pancreas,proton pump inhibitors,sprue
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要